NSE shareholding pattern
Aurobindo Pharma Limited shareholding pattern
As of the Jun 2026 shareholding pattern, filed 2026-06-30, promoters held 51.88%, FIIs 16.38%, and DIIs 25.05% of Aurobindo Pharma Limited (AUROPHARMA). In the Mar 2026 pattern the same figures were promoter 51.82%, FII 15.24% and DII 25.82%. Promoter holding changed between the two filings, so the percentages moved for every category and the difference is not a count of shares bought or sold. The table below shows how promoter, FII, DII and public holding has moved quarter by quarter, taken from the NSE shareholding pattern.
Definition
A shareholding pattern is the quarterly breakdown of who owns a listed company, split across promoters, foreign institutional investors (FII), domestic institutional investors (DII), and the public. Indian companies file it every quarter under SEBI listing rules. Source: NSE shareholding pattern.
Aurobindo Pharma Limited shareholding by quarter
| Quarter | Promoter % | FII % | DII % | Public % | Filed |
|---|---|---|---|---|---|
| Jun 2026 | 51.88 | 16.38 | 25.05 | 6.69 | 2026-06-30 |
| Mar 2026 | 51.82 | 15.24 | 25.82 | 7.12 | 2026-03-31 |
| Dec 2025 | 51.82 | 13.95 | 27.66 | 6.57 | 2025-12-31 |
| Sep 2025 | 51.82 | 14.21 | 27.6 | 6.37 | 2025-09-30 |
| Jun 2025 | 51.82 | 14.38 | 26.93 | 6.87 | 2025-06-30 |
Disclosures shown are public regulatory filings. Data may be delayed or incomplete. Smart-money entities may no longer hold positions shown. Not investment advice.
Disclosure overlap on Aurobindo Pharma Limited
6 fund managers6 fund managers disclosed positions in Aurobindo Pharma Limited within the same window (May 4, 2026 – Aug 2, 2026), per AMFI mutual-fund portfolios. Who they are — and each underlying filing — is shown inside Flock.
A count of what was filed, per public regulatory filings. Not investment advice.
Related on Flock
- Smart money moves this filing week (insider trades, bulk deals and stake disclosures from the last 7 days)
- All NSE shareholding patterns (browse every company by name)
- What is a 13F filing? (how the US equivalent disclosure works)
- FII and DII activity, sourced and dated
- Today's NSE and BSE bulk and block deals
- When smart money's filings overlap (multi-entity disclosure overlap, explained)
Frequently asked questions
What is the promoter holding in Aurobindo Pharma Limited?
As of the Jun 2026 shareholding pattern, promoters held 51.88% of Aurobindo Pharma Limited (AUROPHARMA). Figures are taken from the NSE shareholding pattern filing dated 2026-06-30 and may change each quarter. Not investment advice.
What is the FII holding in Aurobindo Pharma Limited?
Foreign institutional investors held 16.38% of Aurobindo Pharma Limited as of the Jun 2026 pattern, versus 15.24% in the Mar 2026 pattern. Promoter holding changed between the two filings, so both are levels rather than a change in holding. Source: NSE shareholding pattern, filed 2026-06-30. Not investment advice.
How often is the shareholding pattern updated?
Listed Indian companies disclose their shareholding pattern every quarter under SEBI's listing rules. Flock re-stamps each page when a new quarterly pattern is filed, so the freshness chip reflects the true age of the latest data.
The Smart Money Digest
A free weekly email of notable disclosure activity — every line with its filing date and source link. No advice, just filings. Unsubscribe anytime.